Literature DB >> 1868113

Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab.

D S Wilbur1, S W Hadley, L M Grant, M D Hylarides.   

Abstract

A comparative investigation of the biodistributions of radioiodinated p- and m-iodobenzoyl conjugates of a monoclonal antibody Fab fragment, NR-LU-10 Fab, and the same antibody Fab fragment radioiodinated by the chloramine-T (ChT) method has been carried out in mice. Coinjected, dual-isotope studies in athymic mice with tumor xenografts have demonstrated that there are only minor differences in the in vivo distributions of the iodobenzoyl-labeled Fabs, except in the excretory organs, kidneys, and intestines, where major differences were observed. Similarly, coinjection of either the p-iodobenzoyl or m-iodobenzoyl conjugate of NR-LU-10 Fab with the Fab radioiodinated with ChT/radioiodide into BALB/c mice provided additional data that indicated that the two iodobenzoyl conjugates distributed similar in a number of selected tissues. The tissue-distribution differences of the regioisomeric iodobenzoyl conjugates in relation to the ChT-radioiodinated Fab were large for the stomach and neck, consistent with previous studies. The most notable difference between the two iodobenzoyl conjugates was the kidney activity, where the m-iodobenzoyl conjugate was similar to the directly labeled Fab, but the p-iodobenzoyl-conjugated Fab was higher by nearly a factor of 2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868113     DOI: 10.1021/bc00008a006

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

1.  Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.

Authors:  D Scott Wilbur; Monica S Thakar; Donald K Hamlin; Erlinda B Santos; Ming-Kuan Chyan; Hirohisa Nakamae; John M Pagel; Oliver W Press; Brenda M Sandmaier
Journal:  Bioconjug Chem       Date:  2009-09-04       Impact factor: 4.774

2.  Development and evaluation of a novel radioiodinated vesamicol analog as a sigma receptor imaging agent.

Authors:  Kazuma Ogawa; Hiroya Kanbara; Kazuhiro Shiba; Yoji Kitamura; Takashi Kozaka; Tatsuto Kiwada; Akira Odani
Journal:  EJNMMI Res       Date:  2012-09-28       Impact factor: 3.138

3.  Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.

Authors:  Junichi Taki; Anri Inaki; Hiroshi Wakabayashi; Ichiro Matsunari; Kyoko Imanaka-Yoshida; Kazuma Ogawa; Michiaki Hiroe; Kazuhiro Shiba; Toshimichi Yoshida; Seigo Kinuya
Journal:  EJNMMI Res       Date:  2015-04-02       Impact factor: 3.138

4.  Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.

Authors:  Anzhelika Vorobyeva; Ekaterina Bezverkhniaia; Elena Konovalova; Alexey Schulga; Javad Garousi; Olga Vorontsova; Ayman Abouzayed; Anna Orlova; Sergey Deyev; Vladimir Tolmachev
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.